Exelixis, An IBD 50 Stock, Pulls A Bearish Move With Surprise Cancer Delay

Reported by Yahoo Finance · Published 12 Sep 2026, 4:18 AM MYT (1 d ago)

Summary

Source & full coverage: this summary is aggregated from Yahoo Finance, the original publisher. Read the complete report for full context, data and quotes.

Read the original report at Yahoo Finance →

Most Recent

Hyundai Motor to roll out in-house driver-assist system in 2029 3 hr ago Portfolio Diversification Is the Simplest Way to Lower Risk. Here's How I Build Mine. 4 hr ago Malaysia can take on high-value engineering work done in India, says French group 4 hr ago China just launched a $19,170 electric vehicle 4 hr ago LPL Financial Group Managing Director Sells 308 Shares for $110,100 4 hr ago OpenAI IPO will not happen in 2026 amid AI safety fears, says Altman 4 hr ago

EconPulse

Markets. Economy. Malaysia & The World.

Independent economic news aggregation for Malaysia, Asia and global markets, updated throughout the day.

Company

About Us Editorial Standards & Corrections Privacy Policy

Work With Us

Submit a Press Release Partnerships & Advertising Contact Us RSS Feed

Contact

editor@econpulse.my

Editorial & newsroom enquiries answered within 1–2 business days.

Exelixis, An IBD 50 Stock, Pulls A Bearish Move With Surprise Cancer Delay

Summary

More in Markets

Portfolio Diversification Is the Simplest Way to Lower Risk. Here's How I Build Mine.

China just launched a $19,170 electric vehicle

LPL Financial Group Managing Director Sells 308 Shares for $110,100

American Tower Sees 2026 Growth Trough Before 5G, AI and 6G Catalysts Lift Demand

AI Agents Create Their Own Monitoring Problem. Datadog and Dynatrace Are Racing to Own It

How Much Does a 61-Year-Old Need Invested to Collect $8,600 a Month for Life?